| Detected | Trial | Change |
|---|---|---|
| 2026-06-03 | NCT07581808 Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention |
Recruitment opened |
| 2026-05-14 | NCT06813911 Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants… |
Trial sites expanded: 92 -> 96 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-29 | NCT07615166 Low-Density Lipoprotein Cholesterol Reduction With Alirocumab 150 mg Versus Inclisiran in… | Active, Not Recruiting | |
| 2026-05-27 | NCT07610278 A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06501443 | LATAM LOWERS LDL-C | Hypercholesterolaemia | Recruiting |
| NCT06372925 | Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute… | Plaque, Atherosclerotic | Recruiting |
| NCT07581808 | Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention | Hypercholesterolemia | Recruiting |
| Phase 3 | |||
| NCT06597006 | Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With… | Familial Hypercholesterolemia - Homozygous | Recruiting |
| NCT06813911 | Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants… | Atherosclerotic Cardiovascular Disease (ASCVD) | Recruiting |
| NCT05682378 | Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who… | Heterozygous or Homozygous Familial Hypercholesterolemia | Recruiting |
| NCT06597019 | Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous… | Familial Hypercholesterolemia - Heterozygous | Recruiting |
| NCT07102628 | Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment… | Acute Coronary Syndrome | Recruiting |
| NCT03705234 | A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People… | Atherosclerotic Cardiovascular Disease | Active, Not Recruiting |
| Phase 2 | |||
| NCT07610278 | A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in… | Hypercholesterolaemia | Not Yet Recruiting |
| Not specified | |||
| NCT06287177 | Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment… | Hypercholesterolemia | Recruiting |
| NCT07615166 | Low-Density Lipoprotein Cholesterol Reduction With Alirocumab 150 mg Versus Inclisiran in… | Atherosclerotic Cardiovascular Disease | Active, Not Recruiting |